← Open Payments lookup

ELLIE KOBASHIGAWA: Open Payments

NPI 1710670294 · LEAVENWORTH, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$929 in 44 payments from 10 companies in 2025. Trend: 2023 $394 · 2024 $907 · 2025 $929

Food & beverage: $849Education: $80
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.9$272
Otsuka America Pharmaceutical, Inc.9$147
Vanda Pharmaceuticals Inc.6$142
Teva Pharmaceuticals USA, Inc.6$137
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$93
Alkermes, Inc.3$64
Axsome Therapeutics, Inc.2$32
Tris Pharma Inc1$15
Neurocrine BioSciences, Inc.1$14
ABBVIE INC.1$14

Products named: COBENFY, ABILIFY ASIMTUFII, CAPLYTA, HETLIOZ, AUSTEDO XR, FANAPT, ARISTADA, ABILIFY MAINTENA.

Industry payments across KS — which companies pay providers there.